Rituximab Rat Monoclonal Antibody [Clone ID: MB2 A4]

CAT#: AM05879PU-N

Rituximab rat monoclonal antibody, clone MB2 A4, Purified

Conjugation: Unconjugated FITC HRP



Need it in bulk or conjugated?
Get a free quote

CNY 15,881.00


货期*
4周

规格
    • 200 ug

Product images

Specifications

Product Data
Clone Name MB2 A4
Applications ELISA, FC
Recommend Dilution ELISA: 5 µg/ml as coating antibody.
Flow Cytometry: Use 10 µl of 50 µg/ml diluted antibody to label 106 cells in 100 µl.
Reactivity Human
Host Rat
Clonality Monoclonal
Immunogen F(ab)2 fragment of Rituximab.
Spleen cells from immunised rats were fused with cells of the NS-1 mouse myeloma cell line
Specificity This antibody specifically recognises the idiotypic determinants expressed by the Rituximab humanised monoclonal antibody. It does not recognise other CD20 antibodies.
This antibody has been used in ELISA assays to monitor the levels of Rituximab in patient serum following therapy.
It has been used to detect Rituximab bound to the surface of the Raji B cell line, however detection of Rituximab bound 'in vivo' to B-CLL cells has not been demonstrated. It is possible that complement deposition on Rituximab opsonised cells inhibits binding of the anti-Rituximab antibody to cell bound Rituximab (3).
Formulation TRIS buffered saline pH 8.0
State: Purified
State: Liquid purified IgG fraction from Tissue Culture Supernatant
Preservative: 0.09% Sodium Azide
Concentration lot specific
Purification Affinity Chromatography on Protein G
Conjugation Unconjugated
Storage Condition Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Avoid repeated freezing and thawing.
Background Rituximab is a therapeutic reagent directed against the human CD20 cell surface antigen.
Synonyms Rituxan, MabThera
Reference Data
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...